|
EQS-Ad-hoc: MEDICLIN AG / Key word(s): Forecast/Annual Results
MEDICLIN raises full-year guidance for the 2024 financial year
21-Jan-2025 / 16:36 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Offenburg, 21 January 2025
MEDICLIN raises full-year guidance for the 2024 financial year
MEDICLIN Aktiengesellschaft (Ticker: MED) announces that it is raising its guidance for the 2024 financial year.
Instead of a Group EBIT* between EUR 33.0 and 39.0 million, MEDICLIN now expects a Group EBIT between EUR 48.0 and 54.0 million. The sales forecast for the Group was raised from -2.0 % to 0.0 % to now 1.0 % to 3.0 %.
The preliminary figures for the fourth quarter and the 2024 financial year will be published on 27 February 2025.
* As defined on the company's website at the following linkContact for further information:
MEDICLIN Aktiengesellschaft
Okenstraße 27
77652 Offenburg
Ender Gülcan
Head of Investor Relations and Sustainability
Tel.: 0781/488-326
Fax: 0781/488-184 ender.guelcan@mediclin.dewww.mediclin.de
End of Inside Information
21-Jan-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
MEDICLIN AG |
|
Okenstraße 27 |
|
77652 Offenburg |
|
Germany |
| Phone: |
+49 (0)781 488-326 |
| Fax: |
+49 (0)781 488-184 |
| E-mail: |
ender.guelcan@mediclin.de |
| Internet: |
www.mediclin.de |
| ISIN: |
DE0006595101 |
| WKN: |
659510 |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
2071983 |
| |
| End of Announcement |
EQS News Service |
2071983 21-Jan-2025 CET/CEST
